RACHEL MCCRAY: Open Payments
NPI 1336912385 · LINCOLN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$671 in 27 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $559 · 2025 $671
Food & beverage: $671
| Company | Payments | Amount |
|---|---|---|
| Smith+Nephew, Inc. | 3 | $157 |
| Vanda Pharmaceuticals Inc. | 2 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| CSL Behring | 2 | $44 |
| Janssen Biotech, Inc. | 2 | $43 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $39 |
| Amneal Pharmaceuticals LLC | 2 | $36 |
| Neurocrine BioSciences, Inc. | 2 | $32 |
| Itamar Medical Inc | 1 | $29 |
| SK Life Science, Inc. | 1 | $27 |
Products named: OASIS, PONVORY, GLASSIA, Hizentra, JOURNAVX, CREXONT, INGREZZA, WatchPATONE.
Industry payments across IL — which companies pay providers there.
